Distributes pharmaceutical drugs to pharmacies and hospitals.
Jun 2026Revenue $411B/yrExpenses $404B/yr
No trend
Figures by year
Is Mckesson profitable?
Yes. In the 12 months to Jun 2026, revenue was $411B and expenses $404B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2026 | $403B | $397B | $6.21B |
| Mar 2025 | $359B | $355B | $4.42B |
| Mar 2024 | $309B | $305B | $3.91B |
| Mar 2023 | $277B | $272B | $4.38B |
| Mar 2022 | $264B | $262B | $2.04B |
| Mar 2021 | $238B | $243B | −$5.04B |
| Mar 2020 | $231B | $229B | $2.49B |
| Mar 2019 | $214B | $213B | $886M |
| Mar 2018 | $208B | $208B | $762M |
| Mar 2017 | $199B | $191B | $7.12B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.